66
Views
6
CrossRef citations to date
0
Altmetric
Research Article

The use of CT perfusion to monitor the effect of hypocapnia during laser thermal therapy in a rabbit model

, &
Pages 461-479 | Published online: 09 Jul 2009

  • Levin W, Sherar MD, Cooper B, Hill RP, Hunt JW, Liu FF. Effect of vascular occlusion on tumour temperatures during superficial hyperthermia. Int J Hyperthermia 1994; 10: 495-505.
  • Lagendijk JJ. The influence of bloodflow in large vessels on the temperature distribution in hyperthermia. Phys MedBiol 1982; 27: 17-23.
  • Patterson J, Strang R. The role of blood flow in hyperthermia. Int J Radiat Oncol Biol Phys 1979; 5: 235-41.
  • Brown SL, Hunt JW, Hill RP. Differential thermal sensitivity of tumour and normal tissue microvascular response during hyperthermia. Int J Hyperthermia 1992; 8: 501-14.
  • Teicher BA. Physiologic mechanisms of therapeutic resistance: blood flow and hypoxia. Hematol Oncol Clin North Am 1995; 9: 475-506.
  • Voorhees WD, Babbs CF. Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. Eur J Cancer Clin Oncol 1982; 18: 1027-33.
  • Kozin SV, Hasegawa T, Kozina LV, Imamura M, Akagi K, Tanaka Y, et al. The use of a hypoxic cell radiosensitizer AK-2123 gave no improvement in thermoradiotherapy combined with hydralazine. Int J Hyperthermia 1996; 12: 771-7.
  • Kozin SV, Hasegawa T, Ha-Kawa SK, Akagi K, Tanaka Y. Hydralazine at thermoradiotherapy: tumor size and blood flow effects. Int J Radiat Oncol Biol Phys 1994; 29: 50510.
  • Ohshima T, Tanaka Y. Effect of hydralazine on the blood flow of normal and tumor tissues in hyperthermia. Nippon Igaku Hoshasen Gakkai Zasshi 1993; 53: 960-9.
  • Honess DJ, Hu DE, Bleehen NM. A study of the mechanism of hydralazine enhancement of thermal damage in the KHT tumour. Int J Hyperthermia 1991; 7: 667-79.
  • Dewhirst MW, Prescott DM, Clegg S, Samulski TV, Page RL, Thrall DE, et al. The use of hydralazine to manipulate tumour temperatures during hyperthermia. Int J Hyperthermia 1990; 6: 971-83.
  • Horsman MR, Christensen KL, Overgaard J. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. Int J Hyperthermia 1989; 5: 123-36.
  • Tozer GM, Maxwell RJ, Griffiths JR, Pham P. Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension. Br J Cancer 1990; 62: 553-560.
  • Burney IA, Maxwell RJ, Field SB, McCoy CL, Griffiths JR. Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy. Acta Oncol 1995; 34: 367-71.
  • Andrade SP, Hart IR, Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol 1992; 107: 1092-5.
  • Wood PJ, Sansom JM, Butler SA, Stratford IJ, Cole SM, Szabo C, et al. Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitroL-arginine. Cancer Res 1994; 54: 6458-63.
  • Tozer GM, Prise VE, Bell KM. The influence of nitric oxide on tumour vascular tone. Acta Oncol 1995; 34: 373-7.
  • Meyer RE, Shan S, DeAngelo J, Dodge RK, Bonaventura J, Ong ET, et al. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br J Cancer 1995; 71: 1169-74.
  • Fukumura D, Yuan F, Endo M, Jain RK. Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am J Pathol 1997; 150: 713-25.
  • Hahn JS, Braun RD, Dewhirst MW, Shan S, Snyder SA, Taube JM, et al. Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure. Radiat Res 1997; 147: 185-94.
  • Tozer GM, Prise VE, Chaplin DJ. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res 1997; 57:94855.
  • Purdie TG, Lee TY, lizuka M, Sherar MD. Dynamic contrast enhanced CT measurement of blood flow during interstitial laser photocoagulation: comparison with an Arrhenius damage model. Phys Med Biol 2000; 45: 1115-26.
  • James HE, Langfitt TW, Kumar VS, Ghostine SY. Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir 1977; 36: 189-200.
  • Yoshihara M, Bandoh K, Marmarou A. Cerebrovascular carbon dioxide reactivity assessed by intracranial pressure dynamics in severely head injured patients. / Neurosurg 1995; 82: 386-93.
  • Young WL, Freymond D, Ravussin P. Is there still a place for routine deep hypocapnia in intracranial surgery? Ann Fr Anesth Reanim 1995; 14: 70-6.
  • Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol 2001; 46: 3161-75.
  • Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. Appl Physiol 1954; 6: 731-44.
  • Cenic A, Nabavi DG, Craen RA, GeIb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: a validation study. Am J Neuroradiol 1999; 20: 63-73.
  • Bassingthwaighte JB, Chinard FP, Crone C, Lassen NA, Perl W. Definitions and terminology for indicator dilution methods. In: Crone C, Lassen NA, eds, Capillary Permeability. Copenhagen: Munskgaard, 1970; 665-9.
  • St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 1998; 18: 1365-77.
  • Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787-800.
  • Rowell NP, Flower MA, McCready VR, Cronin B, Horwich A. The effects of single dose oral hydralazine on blood flow through human lung tumours. Radiother Oncol 1990; 18: 283-92.
  • Horsman MR, Christensen KL, Overgaard J. Relationship between the hydralazineinduced changes in murine tumor blood supply and mouse blood pressure. Int J Radiat Oncol Biol Phys 1992; 22: 455-8.
  • Kalmus J, Okunieff P, Vaupel P. Dose-dependent effects of hydralazine on microcirculatory function and hyperthermic response of murine FSaIl tumors. Cancer Res 1990; 50: 15-19.
  • Okunieff P, Kallinowski F, Vaupel P, Neuringer LJ. Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy. J Natl Cancer Inst 1988; 80: 745-50.
  • Chaplin DJ, Hill SA, Bell KM, Tozer GM. Modification of tumor blood flow: current status and future directions. Semin Radiat Oncol 1998; 8: 151-63.
  • Whelan WM, Wyman DR, Wilson BC. Investigations of large vessel cooling during interstitial laser heating. Med Phys 1995; 22: 105-15.
  • Matthewson K, Coleridge-Smith P, O'Sullivan JP, Northfield TC, Bown SG. Biological effects of intrahepatic neodymium:yttrium-aluminum-garnet laser photocoagulation in rats. Gastroenterology 1987; 93: 550-7.
  • Okazaki K, Okutsu Y, Fukunaga A. Effects of carbon dioxide (hypocapnia and hypercapnia) on tissue blood flow and oxygenation of liver, kidney and skeletal muscle in the dog. Masui 1989; 38: 457-64.
  • Cenic A, Nabavi DG, Craen RA, GeIb AW, Lee TY. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. Am J Neuroradiol 2000; 21: 462-70.
  • Dudar TE, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984; 44: 605-12.
  • Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48: 2641-58.
  • Nunn JF. Nunn's Applied Respiratory Physiology, 4th edn. Oxford: Butterworth Heinemann, 1993.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.